학술논문

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
Document Type
Article
Source
In: Nature Medicine. (Nature Medicine, November 2023, 29(11):2919-2928)
Subject
Language
English
ISSN
1546170X
10788956